眼科医疗概念股盘中拉升，莎普爱思午后涨停，兴齐眼药涨超10%，立方制药此前涨停，百诚医药、爱 博医疗、光正眼科、何氏眼科等跟涨。 ...

资金面上看，今日眼科医疗概念板块获主力资金净流入1.72亿元，其中，22股获主力资金净流入，8股 主力资金净流入超千万元，净流入资金居首的是恒瑞医药，今日主力资金净流入1.87亿元，净流入资金 居前的还有莱美药业、兴齐眼药、贝达药业等，主力资金分别净流入7209.21万元、3189.88万元、 1914.17万元。 截至7月14日收盘，眼科医疗概念上涨1.49%，位居概念板块涨幅第10，板块内，35股上涨，莱美药业 20%涨停，冠昊生物、泰恩康、江河集团等涨幅居前，分别上涨6.04%、5.36%、5.07%。跌幅居前的有 创维数字、爱博医疗、爱尔眼科等，分别下跌1.23%、1.22%、1.12%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | PEEK材料 | 3.87 | 短剧游戏 | -1.89 | | 减速器 | 2.25 | 信托概念 | -1.87 | | 超超临界发电 | 1.82 | 期货概念 | -1.83 | | 人形机器人 | 1.70 | 快手概念 | -1.60 | | 金属铅 | ...

截至6月3日收盘，眼科医疗概念上涨3.08%，位居概念板块涨幅第10，板块内，42股上涨，冠昊生物 20%涨停，ST中珠涨停，诺思兰德、海特生物、贝达药业等涨幅居前，分别上涨18.82%、13.18%、 7.34%。跌幅居前的有康弘药业、创维数字、江河集团等，分别下跌2.16%、2.05%、1.60%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 中韩自贸区 | 4.23 | 特钢概念 | -0.93 | | 细胞免疫治疗 | 3.87 | 医疗废物处理 | -0.51 | | 重组蛋白 | 3.64 | 同花顺果指数 | -0.41 | | 足球概念 | 3.56 | 无线充电 | -0.39 | | 毛发医疗 | 3.51 | 光热发电 | -0.33 | | CRO概念 | 3.41 | 深圳国企改革 | -0.24 | | 创新药 | 3.38 | F5G概念 | -0.23 | | 培育钻石 | 3.11 | 租售同权 | -0.22 | | 仿制药一致性评价 | 3.08 | 一体化压铸 | ...

Core Viewpoint - The ophthalmology medical concept sector has shown a positive performance, with a 1.30% increase, ranking fifth among concept sectors, driven by significant gains in several stocks [1][2]. Group 1: Sector Performance - The ophthalmology medical concept sector saw 28 stocks rise, with notable performers including Innovation Medical, *ST Jingfeng, and others reaching their daily limit up [1]. - Key gainers in the sector included Innovation Medical (+14.87%), Guanhao Biological (+8.88%), and Kanghong Pharmaceutical (+7.84%) [1]. - Conversely, the sector also experienced declines, with major losers being Skyworth Digital (-3.19%), Jincheng Pharmaceutical (-2.40%), and Doctor Eye Glasses (-2.10%) [1]. Group 2: Capital Flow - The ophthalmology medical concept sector attracted a net inflow of 208 million yuan, with 23 stocks receiving net inflows, and 8 stocks exceeding 10 million yuan in net inflow [2]. - The leading stock in terms of net capital inflow was Innovation Medical, which saw a net inflow of 378 million yuan, followed by Kanghong Pharmaceutical and Hengfeng Information with net inflows of 66.97 million yuan and 46.49 million yuan, respectively [2][3]. - The net inflow ratios for top stocks included Innovation Medical (26.37%), *ST Jingfeng (17.55%), and Hengfeng Information (13.55%) [3].